E-MAGMA: an eQTL-informed method to identify risk genes using genome-wide association study summary statistics
Zachary F Gerring1, Angela Mina-Vargas1, Eric R Gamazon2,3,4
1Mental Health, Translational Neurogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Bioinformatics (Oxford, England)
|February 24, 2021
Summary
E-MAGMA identifies novel candidate causal genes by integrating genome-wide association study data with tissue-specific expression quantitative trait loci (eQTL) information. This method improves understanding of complex disorders by pinpointing genes influencing traits and diseases.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Genome-wide association studies (GWAS) identify genetic loci for traits/diseases, but causal genes remain largely unknown.
- Risk variants often reside in non-coding regions and influence gene expression (eQTL) in a tissue-specific manner.
Purpose of the Study:
- To develop a novel framework, E-MAGMA, for converting GWAS summary statistics into gene-level statistics.
- To leverage tissue-specific eQTL information to assign risk variants to putative causal genes.
Main Methods:
- E-MAGMA integrates GWAS summary statistics with tissue-specific eQTL data.
- The framework assigns genetic risk variants to potential target genes based on eQTL profiles.
- Performance was evaluated using simulated data and real GWAS data for neuropsychiatric disorders.
Main Results:
- E-MAGMA outperformed existing eQTL-informed gene-based methods in simulations.
- The method identified a greater number of putative candidate causal genes for neuropsychiatric disorders.
- Tissue-specific eQTL integration enhances the identification of genes underlying complex traits.
Conclusions:
- E-MAGMA is an effective tool for identifying novel candidate causal genes from GWAS data.
- The framework advances the understanding of the genetic architecture of complex diseases.
- Integrating eQTL data provides crucial insights into gene function and disease mechanisms.


